SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 135 filers reported holding SERES THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,539 | -48.5% | 48,546 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $224,268 | +16.3% | 46,820 | +37.7% | 0.00% | 0.0% |
| Q1 2023 | $192,814 | +3.3% | 34,006 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $186,648 | -13.2% | 33,330 | -0.4% | 0.00% | -50.0% |
| Q3 2022 | $215,000 | +90.3% | 33,451 | +1.4% | 0.00% | +100.0% |
| Q2 2022 | $113,000 | -54.1% | 32,978 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $246,000 | -20.1% | 34,554 | -6.6% | 0.00% | -50.0% |
| Q4 2021 | $308,000 | +16.2% | 36,988 | -2.9% | 0.00% | +100.0% |
| Q3 2021 | $265,000 | -71.5% | 38,094 | -2.3% | 0.00% | -66.7% |
| Q2 2021 | $930,000 | +40.3% | 38,999 | +21.1% | 0.00% | +50.0% |
| Q1 2021 | $663,000 | -15.8% | 32,191 | +0.3% | 0.00% | -33.3% |
| Q4 2020 | $787,000 | -12.5% | 32,105 | +1.1% | 0.00% | -25.0% |
| Q3 2020 | $899,000 | +602.3% | 31,748 | +18.1% | 0.00% | +300.0% |
| Q2 2020 | $128,000 | +66.2% | 26,874 | +24.4% | 0.00% | – |
| Q1 2020 | $77,000 | -2.5% | 21,595 | -5.5% | 0.00% | – |
| Q4 2019 | $79,000 | -14.1% | 22,843 | -0.8% | 0.00% | – |
| Q3 2019 | $92,000 | +109.1% | 23,035 | +69.0% | 0.00% | – |
| Q2 2019 | $44,000 | -51.1% | 13,634 | +3.8% | 0.00% | – |
| Q1 2019 | $90,000 | +47.5% | 13,131 | -3.1% | 0.00% | – |
| Q4 2018 | $61,000 | -41.3% | 13,555 | -0.8% | 0.00% | – |
| Q3 2018 | $104,000 | -9.6% | 13,660 | +1.8% | 0.00% | – |
| Q2 2018 | $115,000 | +19.8% | 13,414 | +2.6% | 0.00% | – |
| Q1 2018 | $96,000 | -31.4% | 13,073 | -5.1% | 0.00% | – |
| Q4 2017 | $140,000 | -36.4% | 13,777 | +0.5% | 0.00% | -100.0% |
| Q3 2017 | $220,000 | +53.8% | 13,712 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $143,000 | +15.3% | 12,687 | +15.6% | 0.00% | – |
| Q1 2017 | $124,000 | +22.8% | 10,977 | +7.1% | 0.00% | – |
| Q4 2016 | $101,000 | -99.9% | 10,250 | -0.3% | 0.00% | -100.0% |
| Q3 2016 | $126,304,000 | -57.6% | 10,277 | +0.1% | 0.00% | 0.0% |
| Q2 2016 | $298,111,000 | +125.8% | 10,262 | +106.4% | 0.00% | 0.0% |
| Q1 2016 | $132,000,000 | – | 4,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 12,682,876 | $93,092,000 | 26.99% |
| ARK Investment Management | 2,406,723 | $17,665,000 | 0.88% |
| Virtus ETF Advisers LLC | 76,713 | $563,000 | 0.49% |
| Bison Wealth, LLC | 33,929 | $249,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 19,525 | $143,000 | 0.10% |
| Rock Springs Capital Management LP | 220,000 | $1,615,000 | 0.07% |
| FEDERATED HERMES, INC. | 1,766,681 | $12,968,000 | 0.04% |
| Spark Investment Management LLC | 79,500 | $583,000 | 0.04% |
| A.R.T. Advisors, LLC | 45,952 | $337,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 88,684 | $651,000 | 0.01% |